https://orcid.org/0000-0001-7400-0263 & Figure 1. The molecular mechanism that regulates the stemness of CD133+ liver cancer stem cells
Figure 2. Therapeutic strategies targeting CD133 in HCC, including antibodies, aptamers, CAR T cells, oncolytic viruses and some drugs or compounds
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
